[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336584-105":59,"doc-detail-336584-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","evaluation-of-anticancer-efficacy-of-d-tocopheryl-polyethylene-glycol-succinate-and-soluplus-mixed-micelles-loaded-with-olaparib-and-rapamycin-against-ovarian-cancer","Evaluation of Anticancer Efficacy of D-α-Tocopheryl Polyethylene-Glycol Succinate and Soluplus® Mixed Micelles Loaded with Olaparib and Rapamycin Against Ovarian Cancer","","Ovarian cancer shows the highest mortality and lowest survival among female reproductive system malignancies, while surgery and chemotherapy remain limited by poor efficacy and constraints. This work formulates D-α-tocopheryl polyethylene-glycol (PEG) 1000 succinate (TPGS) and Soluplus® (SOL) mixed micelles delivering olaparib (PARP inhibitor) with rapamycin (mTOR inhibitor). The system is characterized physicochemically, assessed for in vitro cytotoxicity, and evaluated in vivo for toxicity and antitumor performance. Optimized OLA/RAPA-TPGS/SOL achieves synergistic effects, >65% encapsulation efficiency, sustained stability up to 180 days, high cellular uptake, and significant inhibition of migration, spheroids, and tumor growth.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evaluation-of-anticancer-efficacy-of-d-tocopheryl-polyethylene-glycol-succinate-and-soluplus-mixed-micelles-loaded-with-olaparib-and-rapamycin-against-ovarian-cancer/336584/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evaluation-of-anticancer-efficacy-of-d-tocopheryl-polyethylene-glycol-succinate-and-soluplus-mixed-micelles-loaded-with-olaparib-and-rapamycin-against-ovarian-cancer/336584.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What micellar drug delivery system is evaluated for ovarian cancer?","Question",{"text":112,"@type":113},"D-α-tocopheryl polyethylene-glycol (PEG) 1000 succinate (TPGS) and Soluplus® (SOL) mixed micelles are loaded with olaparib and rapamycin for ovarian cancer therapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the mixed micelles assessed in the study?",{"text":117,"@type":113},"The formulations were prepared at different molar and weight ratios, physicochemically characterized, tested for in vitro cytotoxicity, and further evaluated for in vivo toxicity and antitumor efficacy.",{"name":119,"@type":110,"acceptedAnswer":120},"What formulation showed synergistic and optimized effects?",{"text":121,"@type":113},"A 4:1 TPGS:SOL weight ratio combined with a 2:3 OLA:RAPA molar ratio produced synergistic effects and was selected as optimized.",{"name":123,"@type":110,"acceptedAnswer":124},"What were the key safety and antitumor findings in vivo?",{"text":125,"@type":113},"No toxicity was observed except in the high-dose group, while the optimized formulation markedly inhibited tumor spheroid formation and tumor growth in vivo.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},336584,1790257316,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","International Journal of Nanomedicine Dovepress  \nopen access to scientific and medical research  \n Open Access Full Text Article ORIGINAL RESEARCH  \nEvaluation of Anticancer Efficacy of D-α-Tocopheryl Polyethylene-Glycol Succinate and Soluplus® Mixed Micelles Loaded with Olaparib and Rapamycin Against Ovarian Cancer  \nYu Been Shin 1,*, Ju-Yeon Choi 2,*, Moon Sup Yoon 1, Myeong Kyun Yoo 1, Dae Hwan Shin 1,3,*, Jeong-Won Lee 4,5,*  \n1College of Pharmacy, Chungbuk National University, Cheongju, 28160, Republic of Korea; 2Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; 3Chungbuk National University Hospital, Chungbuk National University, Cheongju, 28644, Republic of Korea; 4Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; 5Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University School of Medicine, Seoul, 06351, Republic of Korea  \n*These authors contributed equally to this work  \nCorrespondence: Dae Hwan Shin, College of Pharmacy, Chungbuk National University, Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju, 28160, Republic of Korea, Tel +82 43 261 2820, Fax +82 43 268 2732, Email [dshin@chungbuk.ac.kr](dshin@chungbuk.ac.kr) ; Jeong-Won Lee, Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81, Irwon-ro, Gangnam-gu, Seoul, South Korea, Zip 06351, Tel\\Fax +82-2-3410-1382, [Email garden.lee@samngsung.com](Email garden.lee@samngsung.com)  \n\n| Purpose: Ovarian cancer has the highest mortality rate and lowest survival rate among female reproductive system malignancies. There are treatment options of surgery and chemotherapy, but both are limited. In this study, we developed and evaluated micelles composed of D-α-tocopheryl polyethylene-glycol (PEG) 1000 succinate (TPGS) and Soluplus® (SOL) loaded with olaparib (OLA), a poly(ADP-ribose)polymerase (PARP) inhibitor, and rapamycin (RAPA), a mammalian target of rapamycin (mTOR) inhibitor in ovarian cancer.\u003Cbr>Methods: We prepared micelles containing different molar ratios of OLA and RAPA embedded in different weight ratios of TPGSand SOL (OLA/RAPA-TPGS/SOL) were prepared and physicochemical characterized. Furthermore, we performed in vitro cytotoxicity experiments of OLA, RAPA, and OLA/RAPA-TPGS/SOL. In vivo toxicity and antitumor efficacy assays were also performed to assess the efficacy of the mixed micellar system.\u003Cbr>Results: OLA/RAPA-TPGS/SOL containing a 4:1 TPGS:SOL weight ratio and a 2:3 OLA:RAPA molar ratio showed synergistic effects and were optimized. The drug encapsulation efficiency of this formulation was >65%, and the physicochemical properties were sustained for 180 days. Moreover, the formulation had a high cell uptake rate and significantly inhibited cell migration (**p \u003C 0.01) . In the in vivo toxicity test, no toxicity was observed, with the exception of the high dose group. Furthermore, OLA/RAPA-TPGS/SOL markedly inhibited tumor spheroid and tumor growth in vivo.\u003Cbr>Conclusion: Compared to the control, OLA/RAPA-TPGS/SOL showed significant tumor inhibition. These findings lay a foundation for the use of TPGS/SOL mixed micelles loaded with OLA and RAPA in the treatment of ovarian cancer.\u003Cbr>Keywords: mixed micelle, combination therapy, nanoformulation, IV formula, antitumor efficacy |\n| --- |\n| Introduction\u003Cbr>Ovarian cancer, which ranks first in mortality among malignant tumors ofthe female reproductive system, has the lowest survival rate of all gynecologic malignancies despite advances in diagnosis and treatment.1,2 Specifically, epithelial ovarian cancer represents about 90% of all malignant ovarian tumors.3 The prevailing treatment approach for this type of cancer typically involves cytoreductive surgery coupled with chemotherapy based on platinum compounds.4,5 Although |\n\nReceived: 14 March 2024  \nAccepted: 2 Jul","cbCaiokJSKoh4I8y","https://ap.wps.com/l/cbCaiokJSKoh4I8y","pdf",9150147,23,"English","# Purpose\n# Methods\n# Results\n# Conclusion\n# Introduction\n# Received, Accepted, Published\n# Graphical Abstract","[{\"question\":\"What micellar drug delivery system is evaluated for ovarian cancer?\",\"answer\":\"D-α-tocopheryl polyethylene-glycol (PEG) 1000 succinate (TPGS) and Soluplus® (SOL) mixed micelles are loaded with olaparib and rapamycin for ovarian cancer therapy.\"},{\"question\":\"How were the mixed micelles assessed in the study?\",\"answer\":\"The formulations were prepared at different molar and weight ratios, physicochemically characterized, tested for in vitro cytotoxicity, and further evaluated for in vivo toxicity and antitumor efficacy.\"},{\"question\":\"What formulation showed synergistic and optimized effects?\",\"answer\":\"A 4:1 TPGS:SOL weight ratio combined with a 2:3 OLA:RAPA molar ratio produced synergistic effects and was selected as optimized.\"},{\"question\":\"What were the key safety and antitumor findings in vivo?\",\"answer\":\"No toxicity was observed except in the high-dose group, while the optimized formulation markedly inhibited tumor spheroid formation and tumor growth in vivo.\"}]","Evaluation of Anticancer Efficacy of D-α-Tocopheryl Polyethylene-Glycol Succinate and Soluplus® Mixed Micelles Loaded with Olaparib and Rapamycin Against Ovarian Cancer | PDF",1790015725,58,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b48dd92b07e8eb65b88c18d22e4b1ec6.webp",983,1272,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47bd312a576e89fa83913170212968d3.webp",982,1270,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/120a217a10af40f23ad9203f49359026.webp",981,1269,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f33898eb5176c20dcbbb8ca6ebb38737.webp",980,1268]